on the cellular level, particularly in the mouse and human gastrointestinal system, wherein c-Myc protein was readily detected in immature proliferating cells at the base of the colonic crypts, while Mad protein distribution was restricted to the postmitotic differentiated cells in the apex of the crypts. An increasing gradient of Mad was also evident in the more differentiated subcorneal layers of the stratified squamous epithelium of the skin. Together, these observations support the view that both downregulation of Myc and accumulation of Mad may be necessary for progression of precursor cells to a growth-arrested, terminally differentiated state.
Cessation of proliferation and onset of terminal differentiation represent pivotal events in the maturation program of all committed cell types. The genetic elements and molecular mechanisms governing these processes are poorly understood. Multiple studies have pointed toward the c-Myc oncoprotein as a potential regulator of these processes, since the loss of c-myc gene expression appears to be a required genetic event for progression of maturing cells through this critical developmental transition (for review see ref. 1) . Additional support for the regulatory role of Myc derives from both its biochemical profile and its biological activities. In particular, Myc functions in part as a sequence-specific transcription factor and can stimulate transcription of reporter genes bearing a Myc consensus binding site (2, 3) . Candidate genes that appear to be regulated by Myc are involved in DNA synthesis (4) and cell cycle regulation (5) , further supporting the view that c-Myc promotes cellular growth. The forced expression of c-myc in cultured cells and transgenic mice can lead to deregulated growth and malignancy and can impede terminal differentiation in diverse cell types (for review see ref. 1) .
Disruption of c-Myc function by gene targeting is associated with severe growth retardation and congenital defects in many developing organs and embryonic structures during early ontogeny and ultimately leads to a lethal condition before or during the onset of organogenesis circa embryonic day 10 (ref. 6 ; H.-W.L. and R.A.D., unpublished observations). The pleiotropic effects associated with c-Myc deficiency most likely relate to the generalized pattern of c-myc expression in both the embryo proper and extraembryonic tissues during this stage of normal development (7, 8) . By embryonic day 18.5, c-myc transcripts are no longer observable in organs that have completed proliferation and instead are restricted to those which maintain proliferating precursor populations (e.g., intestinal crypts, basal skin layer, and thymus; ref. 9) .
Efforts to elucidate how the actions of Myc are regulated have pointed to mechanisms that limit the amount of c-myc mRNA and protein (for review see ref. 10) and to those that block Myc activities such as induction of cellular growth (11, 12) and transcriptional activation (13) . The latter mechanism involves interactions among an extended family of related basic-helix-loop-helix/leucine zipper (bHLH/LZ) proteins that includes Myc, Max, Mad, and Mxil (13) (14) (15) (16) . Myc transactivation function appears to be highly dependent upon its heterodimerization with Max (refs. 14, 15, and 17 and references therein) and the binding of the heterodimer to the Myc consensus sequence (18, 19) . Heterodimers formed between Max and Mad or Mxil lack transactivation activity and may inhibit the expression of Myc-regulated targets through their capacity to competitively occupy the CACGTG consensus (13, 16) and to actively repress those targets (20, 21) . The concept that Mad and Mxil may function as repressors of Myc activity is supported by the biological observations that human mad or mxil overexpression can suppress transformation activity of c-myc in cultured cells (11) and block progression across the G1/S transition of the cell cycle (12) .
From a developmental standpoint, a rise in mad mRNA levels (22) §To whom reprint requests should be addressed.
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The spatially distinct localization of Myc and Mad in the intestinal epithelium argues for a specific in vivo role for Mad in processes of terminal differentiation that is removed from its role as a putative regulator of Myc in these cells. oligonucleotide-primed AZAPII cDNA library generated from RNA derived from newborn mouse brain (Stratagene). Purification of recombinant clones, subcloning, probe preparation and radiolabeling, Northern blotting and hybridizations, and reverse transcription-polymerase chain reaction (RT-PCR) were performed as described (24) . Nucleotide sequence of the mouse mad cDNAI was determined and analyzed as described (25) . Total RNA derived from a panel of newborn and adult mouse tissues was isolated by the LiCl/urea method (26) and subjected to RNase protection assays (24) . Expression Constructs and Rat Embryo Fibroblast (REF) Cooperation Assays. Expression constructs for mouse mad and human mad were generated by placing their respective cDNAs in both orientations between two tandemly repeated Moloney murine leukemia virus long terminal repeats in pVNic (24) . The mouse c-myc and Ha-rasval-l2 expression constructs have been described (27) . Early-passage cultures of REFs were prepared and cotransfected by the calcium phosphate precipitation method (27) . The malignant phenotype of transformed foci was assessed by morphological criteria under a light microscope and in the soft-agar assay (27) .
MATERIALS AND METHODS
Immunohistochemistry. Staged embryonic and postnatal mouse tissues were embedded in OCT cryopreservative solution (Miles), fresh-frozen in liquid N2, and then stored at -70°C. Immunohistochemical stains were performed on cryostat-cut sections (5 ,um) by the avidin-biotin immunoperoxidase method (28) . Adjacent sections were either stained with hematoxylin and eosin or incubated with an anti-Mad antibody (Santa Cruz Laboratories) at a dilution of 1:500, an anti-Myc antibody (Upstate Biotechnology, Lake Placid, NY) at a dilution of 1:1000, or an anti-laminin antibody (Sigma) at a dilution of 1:1000. Sections were then incubated with secondary biotinylated goat anti-rabbit immunoglobulins followed by avidin-biotin-peroxidase complexes (Vector Laboratories).
To verify the specificity of anti-Myc and anti-Mad immunohistochemical staining, antibodies were preincubated with an excess of synthetic peptides to which the antibodies were raised (concentrations of 0. (13) is supported by their shared amino acid identity of 89% compared with only 61% when aligned with the related human Mxi (16) . The majority of the cross-species amino acid differences between mouse and human Mad proteins are highly conservative substitutions, with the exception of an extended repeat of Asp-Val pairs positioned near a highly charged acidic region in the C-terminal portion of the mouse Mad protein. A possible function for this 2-aa repeat is not apparent from a database search; RT-PCR studies do not support the existence of mouse mad transcripts capable of encoding an Asp-Val repeat equivalent in size to that of the human protein (data not shown).
Homology between Mad and Max (14) bHLH/LZ regions (51% similarity) suggests that the DNA-binding/dimerization motifs of Mad will assume a structure similar to that determined crystallographically for Max-namely, one that comprises two continuous a-helices (basic region plus helix I and helix II plus leucine zipper) separated by a loop (19) . With respect to the basic region, residues that have been shown crystallographically for Max (19) and by site-directed mutagenesis for E-box-binding proteins (ref. 38 and references therein) to confer sequence-specific DNA recognition and to participate in anchoring the protein to the major groove are also found in the basic region of mouse Mad. Aside from maintenance of key residues implicated in DNA-binding and dimerization function, the mouse Mad protein also contains specific residues that have been hypothesized (25) to govern the selection or dismissal of dimerization partners through favorable or unfavorable charge interactions on the electrostatic surface.
N-terminal to the bHLH/LZ region of mouse Mad is a region (aa 1-32) markedly conserved throughout vertebrate evolution; it exhibits an overall identity of 88% with human Mad (13) and is highly homologous (75% similar) to similarly positioned regions in both human (16) and mouse (20) Mxi. The secondary structure of this region, as assessed by the PREDICTPROTEIN algorithm (European Molecular Biology Laboratory), is predicted to be strongly a-helical in nature (data not shown). For mouse Mxi, this region has been shown to be essential for potent repression of Myc transforming activity (20) and for binding to the mammalian homolog of the yeast transcriptional repressor Sin3 (20, 21) . The conservation of the primary and secondary structure of this domain suggests that its activities and interactions may be highly similar if not identical in the Mad and Mxi proteins.
C-terminal to the bHLH/LZ region of mouse Mad is a highly charged region (aa 136-219) that is rich in serine and acidic residues, previously termed "similarity region 2" on the basis of homology between human Mad and Mxi proteins (13, 16) . Within similarity region 2 of mouse Mad is a subregion (aa 147-178) of extreme negative charge. This subregion could conceivably facilitate interactions with positively charged histone proteins which could then lead to nucleosome unfolding and allow access of Mxil/Max or Mad/Max complexes to DNA; similar protein/histone interactions have been postulated for excision-repair proteins (29) . Alternatively, this acidic region may allow for sliding of the complexes on chromatin in search of specific DNA-recognition sequences, an activity that has been suggested for a negatively charged subregion in the Myc protein (30) .
Cross-Species Conservation of Suppression by Mad of Myc Transforming Activity. We demonstrated recently that human mad is a powerful inhibitor of myc/ras cotransformation activity in the REF cooperation assay (11) . The highly quantitative nature of this biological assay (31) was used in the present study to determine whether the mouse homolog of mad possessed antioncogenic activities comparable to those of the human gene. Inhibition was assessed by measuring the number of transformed foci generated in cotransfections of mouse c-myc and activated Ha-rasval-l2 in the presence or absence of an equimolar amount of human or mouse mad expression construct. In multiple independent cotransfections, a significant reduction in the number of foci was observed IThe mouse mad sequence has been deposited in the GenBank database (accession no. L38926).
Developmental (Fig. 1) . The decrease in the number of foci was found, on average, to be greater with the human gene than with the similarly designed mouse expression construct. Since virtually all of the other cross-species amino acid differences between the human and mouse mad open reading frames are highly conservative substitutions, this diminished activity may assign significance to the extended Asp-Val repeat in the mouse protein (see above).
The suppressive potential of mouse mad was readily evident with other parameters used to assess the degree of malignant transformation. Cell lines established from the few foci arising in myc/ras/mouse mad cotransfections exhibited a less transformed morphology than cell lines generated from myc/rasinduced foci. The addition of mad to the cotransfections was also associated with a poorer potential for anchorageindependent growth in that only 20% of myc/ras/mouse mad-derived cell lines were capable of growth in soft agar, compared with 80% for c-myc/ras (data not shown). Interestingly, the two myc/ras/mouse mad lines that exhibited anchorage-independent growth had undetectable levels of mad transcripts (data not shown). This observation suggests that strong selective pressure against mad overexpression is operative during the progression toward a highly malignant phenotype, and only those foci that eliminate or diminish mad expression can sustain growth in soft agar.
Contrasting Patterns of Myc and Mad in Developing Tissues. As Mad clearly antagonizes the ability of Myc to neoplastically transform cells in culture, an analysis of mad and myc mRNA and protein expression was performed to understand the functional relationships among these members of the Myc superfamily in the growth and development of normal cells. As an initial assessment, RNase protection assays were used to compare the steady-state levels of mad and myc mRNAs in a panel of developing newborn tissues and terminally differentiated adult tissues (Fig. 2) . Progressive development and growth arrest in most organ systems were accompanied by a dramatic decrease in c-myc mRNA, as described previously (32) , and by a maintenance or substantial increase . .372nt in mad gene expression (Fig. 2 , compare mad and c-myc signals in newborn versus adult intestine and brain). Notably, tissues that did not exhibit this contrasting relationship (e.g., liver) showed persistently high or rising levels of mouse mJxil mRNA in adult tissue (L.C. and R.A.D., unpublished data), a finding consistent with the notion that the structurally related Mad and Mxil may serve redundant roles in terminally differentiated tissues. In mature organ systems which undergo perpetual renewal (such as the gastrointestinal tract and skin) or extensive postnatal development (such as the lung), high levels of mRNA for both c-myc and mad continued to be present in the adult.
Although these expression patterns suggest differential activities for myc and mad with progression through development, the cell type heterogeneity of whole organs precludes a detailed view of how myc and mad expression relates to processes of growth and differentiation of the individual cell lineages within each organ. Consequently, an immunohistochemical analysis of Myc and Mad protein in the gastrointestinal tract and skin was performed to determine their patterns of expression at the microanatomical level (Fig. 3) . Selection of the gut and epidermis was dictated by the high levels of mad mRNA in these tissues and by the well-characterized morphological and biological changes that accompany epithelial cell growth and differentiation therein.
In the colon, the base of each crypt contains multipotent stem cells which undergo several rounds of cell division before committing along several possible lineages to become goblet cells, enterocytes, and enteroendocrine cells (33) . These postmitotic committed lineages continue to differentiate as they migrate vertically toward the gut lumen and, upon reaching the apex, undergo apoptosis and are extruded into the lumen (33) . In multiple sections of the gastrointestinal tract of the adult mouse, the lower portion of the colonic crypts, comprising slowly proliferating progenitor cells, showed a strong nuclearassociated immunoreactivity to a c-Myc-specific antibody (Fig.  3A) . Similarly, the midportion of the crypts, populated by maturing and rapidly proliferating cells, displayed positive Proc. Natl. Acad. Sci. USA 92 (1995) .z ; ĵ ; , . . . . . . . . . . .   , , . , . ; s ,  § . . . ; t r : N s * X , ) ' , . ' . ' ; , ; . . . c-Myc staining. However, c-Myc immunoreactivity was undetectable in sections through the luminal portion of the crypts wherein differentiated nondividing cells reside. This regional pattern of Myc protein expression is identical to that observed at the mRNA level (9) . In sharp contrast to c-Myc, intense nuclear immunostaining for Mad was observed in cells of the apical or luminal portion of the adult colonic crypts but not in the cells of the middle and lower portions of colonic crypts (Fig. 3B) . While a similar pattern of expression was observed in the colonic tissues of newborn mice, the distribution of c-Myc was more diffuse and cytoplasmic, whereas Mad proteins were clearly nuclear-associated in the apical cells of the colonic crypts ( Fig. 3C ; only Mad is shown). Analogous results were obtained when normal adult human colonic tissue samples were analyzed (data not shown).
The discrete cell layers of the stratified squamous epithelium of the epidermis include the basal layer, in which some precursor cells are proliferatively active; the spinous and granular layers, consisting of actively differentiating cells; and the stratum corneum, comprising terminally differentiated cells (34) . Definitive localization of the basal layer was made possible by anti-laminin staining of the basement membrane upon which the basal layer sits (data not shown). Adjacent sections stained with the anti-Mad antibody showed low or undetectable cytoplasmic and nuclear staining in the proliferating and less mature cells of the basal layer and an increasing gradient of strong cytoplasmic and nuclear immunoreactivity in cells of the maturing suprabasal layers (Fig. 3D) . Ultimately, Mad expression was lost as terminally differentiated keratinocytes reached the superficial stratum corneum and underwent apoptosis and denucleation (Fig. 3D) (12) . A requisite feature of such a yin-yang relationship in cell lineages progressing towards the growth-arrested and fully differentiated state would be some degree of temporal and/or spatial overlap between Myc and Mad expression. This appears to be the case in the stratified squamous epithelium where some, albeit weak and variable, expression of Mad is detectable in the c-Myc-expressing basal layer. In sharp contrast, the compartmentalization of Myc and Mad proteins in anatomically distinct zones of the gut suggests separable roles for these two proteins in the regulation of cellular proliferation and differentiation in this organ. The restricted expression of Myc to the base of the colonic crypt supports a role for Myc in active cellular proliferation and/or maintenance of an undifferentiated state. The absence of Myc and the appearance of Mad expression in highly differentiated gut epithelial cells well after their withdrawal from the cell cycle suggest that Mad performs functions beyond competing with Myc for commonly regulated gene targets in some cell lineages. Rather, in tissues wherein Mad is expressed but Myc is not, Mad may play a role in regulation of genes required for completion (rather than initiation) of the terminal differentiation program. Lastly, in tissues where mad gene expression is extremely low or is downregulated during development, this differentiation function may be served by the highly related Myc antagonist, Mxil. Indeed, in the developing kidney, very abundant levels of mxil mRNA are present and these levels increase substantially with advancing age (data not shown).
Our findings suggest that a given cell may need both the down regulation of Myc and the up regulation of Mad (or Mxi) to achieve its developmental end point. Support for this view comes from other studies in which molecular strategies designed to neutralize the actions of Myc (e.g., antisense synthetic oligonucleotides or RNA) have proven only partially effective in triggering terminal differentiation and, in most instances, have served only to accelerate differentiation upon exposure to differentiation-inducing agents (35, 36) . A study assessing the phenotypic impact of Myc neutralization (e.g., dominant negative forms of Myc) coupled with direct induction of Mad expression may provide insight into how members of the Myc superfamily participate and cooperate mechanistically in important developmental transitions.
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